NSPR InspireMD, Inc.

BEARISH Impact: 6/10 424B5
Horizon weeks Filed Apr 3, 2026 Processed 2mo ago SEC 0001493152-26-015121
Notable filing: 424B5
Latest settled — T+20d ⚠ clustered
NSPR ▼ -21.48% at T+20d
SHORT call ✓ call won +21.48% · α vs SPY +30.46% · entry $1.49 → $1.17
Next anchor: T+60d in 20d
Currently $0.7654 · +48.63% from $1.49 entry (call sign-flipped)
Entry anchored
Apr 2, 03:36 PM ET
via Databento tick
T+1d
-6.71%
call +6.71% · α +6.77%
$1.39
settled 2mo ago
T+5d
-9.40%
call +9.40% · α +13.53%
$1.35
settled 2mo ago
T+20d
-21.48%
call +21.48% · α +30.46%
$1.17
settled 6w ago
T+60d
call — · α —
in 20d

Price Chart

Loading chart...

Executive Summary

InspireMD is establishing an at-the-market equity offering program to sell up to $75 million of common stock through BTIG as sales agent. The offering allows for flexible, opportunistic capital raising over time, with shares sold at market prices. The company faces substantial doubt about its ability to continue as a going concern and has a history of recurring losses.

Actionable Insight

Monitor the pace and pricing of share sales through this ATM program, as continued dilutive offerings could pressure the stock price. Watch for any sales below the $1.3827 conversion price of Series C Preferred Stock, which would trigger additional dilution. The company's ability to execute on its commercialization plans with this capital will be critical to reversing the bearish sentiment.

Key Facts

  • Company is offering up to $75,000,000 of common stock through an at-the-market offering with BTIG as sales agent
  • Last reported stock price was $1.59 per share on March 27, 2026
  • Company has substantial doubt about its ability to continue as a going concern
  • Series C Preferred Stock has full ratchet anti-dilution protection that could significantly dilute common shareholders
  • Net tangible book value was $1.28 per share as of December 31, 2025, creating immediate dilution for new investors

Financial Impact

Up to $75 million in gross proceeds, with potential for significant additional dilution from anti-dilution provisions on Series C Preferred Stock

dilutiondebtcashFlow

Risk Factors

  • Significant dilution to existing shareholders from the offering and potential anti-dilution adjustments
  • Substantial doubt about the company's ability to continue as a going concern
  • History of recurring losses and negative cash flows from operations
  • Potential for shares to be sold at prices significantly below current market levels

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001493152-26-015121
Document: 0001493152-26-015121-index-headers.html0001493152-26-015121
Document: 0001493152-26-015121-index.html0001493152-26-015121
Document: 0001493152-26-015121.txt0001493152-26-015121
11 reports for NSPR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+20▲ +15.38%May 1, 2026
Filters
Rows
Reports for NSPR — sortable, filterable
Type Now
May 21, 2026
19d ago
Insider Cluster
NEUTRAL ★ 4/10
$1.00 $0.9900▼ −1.00%▼ −2.66%$0.7654 (−23.46%)
May 15, 2026
25d ago
Insider Cluster
BULLISH ★ 6/10
$1.05 $0.9500▼ −9.52%▼ −11.14%$0.7654 (−27.10%)
May 7, 2026
4w ago
Insider Cluster
BULLISH ★ 5/10
$1.16 $1.17▲ +0.86%▼ −0.64%$0.7654 (−34.02%)
May 1, 2026
5w ago
8-K
BEARISH ★ 7/10
$1.17 $1.25▼ −6.84%▼ −3.90%$0.7654 (+34.58%)
May 1, 2026
5w ago
Press Release
BEARISH ★ 7/10
$1.17 $1.25▼ −6.84%▼ −3.90%$0.7654 (+34.58%)
May 1, 2026
5w ago
Press Release
BULLISH ★ 6/10
$1.17 $1.25▲ +6.84%▲ +3.90%$0.7654 (−34.58%)
Apr 22, 2026
6w ago
DEFA14A
NEUTRAL ★ 4/10
$1.28 $1.14▼ −10.94%▼ −12.42%$0.7654 (−40.20%)
Apr 20, 2026
7w ago
DEFA14A
NEUTRAL ★ 3/10
$1.33 $1.14▼ −14.29%▼ −15.37%$0.7654 (−42.45%)
Apr 3, 2026
9w ago
424B5
BEARISH ★ 6/10
$1.49 $1.35▲ +9.40%▲ +13.53%$0.7654 (+48.63%)
Mar 18, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$1.79 $1.77▼ −1.12%▼ −0.40%$0.7654 (−57.24%)
Showing 10 of 11

US Market Status

Market Closed — Opens Thu (10h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access